Cardiff Lexington Corp (CDIX) stock
CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026Market cap $550.31KP/E –Yield –
Cardiff Lexington total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cardiff Lexington's total debt was $0 at Jun 30, 2025. For fiscal 2024 it was $3.62M, up 4041.1% from the year before. Over ten years it grew 53.5% a year on average. The highest annual figure on record is $3.62M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.62M | +4041.1% |
| FY2023 | Dec 31, 2023 | $87.46K | -96.5% |
| FY2022 | Dec 31, 2022 | $2.49M | +152.9% |
| FY2020 | Dec 31, 2020 | $985.80K | +59.7% |
| FY2019 | Dec 31, 2019 | $617.35K | -36.6% |
| FY2018 | Dec 31, 2018 | $973.54K | +170.3% |
| FY2017 | Dec 31, 2017 | $360.17K | -15.5% |
| FY2016 | Dec 31, 2016 | $426.02K | +136.3% |
| FY2015 | Dec 31, 2015 | $180.31K | +39.7% |
| FY2014 | Dec 31, 2014 | $129.03K | +158.1% |
| FY2013 | Dec 31, 2013 | $50.00K | -93.9% |
| FY2012 | Dec 31, 2012 | $824.24K | +8.6% |
| FY2011 | Dec 31, 2011 | $759.24K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $3.62M | +4041.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.62M | +4041.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.62M | +6059.5% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $87.46K | -96.5% |
| Q3 FY2023 | Sep 30, 2023 | $87.46K | -96.5% |
| Q2 FY2023 | Jun 30, 2023 | $58.80K | -98.8% |
| Q1 FY2023 | Mar 31, 2023 | $58.80K | -98.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.49M | +216.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.47M | +117.1% |
| Q2 FY2022 | Jun 30, 2022 | $4.79M | +385.9% |
| Q1 FY2022 | Mar 31, 2022 | $4.79M | +301.2% |
| Q2 FY2021 | Jun 30, 2021 | $787.85K | -34.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.14M | +39.7% |
| Q4 FY2020 | Dec 31, 2020 | $985.80K | +59.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.19M | +99.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.19M | +43.9% |
| Q1 FY2020 | Mar 31, 2020 | $814.92K | -2.4% |
| Q4 FY2019 | Dec 31, 2019 | $617.35K | -36.6% |
| Q3 FY2019 | Sep 30, 2019 | $597.63K | -39.9% |
| Q2 FY2019 | Jun 30, 2019 | $830.19K | +230.5% |
| Q1 FY2019 | Mar 31, 2019 | $834.66K | +132.7% |
| Q4 FY2018 | Dec 31, 2018 | $973.54K | +170.3% |
| Q3 FY2018 | Sep 30, 2018 | $994.89K | +162.8% |
| Q2 FY2018 | Jun 30, 2018 | $251.18K | -33.6% |
| Q1 FY2018 | Mar 31, 2018 | $358.64K | -6.8% |
| Q4 FY2017 | Dec 31, 2017 | $360.17K | -15.5% |
| Q3 FY2017 | Sep 30, 2017 | $378.54K | – |
| Q2 FY2017 | Jun 30, 2017 | $378.55K | – |
| Q1 FY2017 | Mar 31, 2017 | $384.88K | – |
| Q4 FY2016 | Dec 31, 2016 | $426.02K | – |
See a number that looks wrong?